rs372226064
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_000393.5(COL5A2):c.4096A>G(p.Met1366Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000253 in 1,461,184 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000393.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A2 | NM_000393.5 | c.4096A>G | p.Met1366Val | missense_variant | Exon 52 of 54 | ENST00000374866.9 | NP_000384.2 | |
COL5A2 | XM_011510573.4 | c.3958A>G | p.Met1320Val | missense_variant | Exon 55 of 57 | XP_011508875.1 | ||
COL5A2 | XM_047443251.1 | c.3958A>G | p.Met1320Val | missense_variant | Exon 57 of 59 | XP_047299207.1 | ||
COL5A2 | XM_047443252.1 | c.3958A>G | p.Met1320Val | missense_variant | Exon 56 of 58 | XP_047299208.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL5A2 | ENST00000374866.9 | c.4096A>G | p.Met1366Val | missense_variant | Exon 52 of 54 | 1 | NM_000393.5 | ENSP00000364000.3 | ||
COL5A2 | ENST00000618828.1 | c.2935A>G | p.Met979Val | missense_variant | Exon 45 of 47 | 5 | ENSP00000482184.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461184Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 726956
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
The p.M1366V variant (also known as c.4096A>G), located in coding exon 52 of the COL5A2 gene, results from an A to G substitution at nucleotide position 4096. The methionine at codon 1366 is replaced by valine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Ehlers-Danlos syndrome, classic type, 1 Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1366 of the COL5A2 protein (p.Met1366Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with COL5A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 519680). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt COL5A2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at